A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in
the treatment of an episodic cluster headache period compared to placebo (medically inactive
substance which does not contain any active ingredients).